Related references
Note: Only part of the references are listed.Features of Potentially Predictive Biomarkers of Chemotherapeutic Efficacy in Small Cell Lung Cancer
Alberto A. Chiappori et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Quantitative Analysis of Tumor in Bronchial Biopsy Specimens
Caroline L. Coghlin et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer
Christine L. Hann et al.
CANCER RESEARCH (2008)
Activity of the Bcl-2 family inhibitor ABT-263 in a panel of small cell lung cancer xenograft models
Alex R. Shoemaker et al.
CLINICAL CANCER RESEARCH (2008)
Tissue microarrays: emerging standard for biomarker validation
Saima Hassan et al.
CURRENT OPINION IN BIOTECHNOLOGY (2008)
Randomized phase II study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer:: CALGB 30103
Charles M. Rudin et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Expression of excision repair cross-complementation group 1 protein predicts poor outcome in patients with small cell lung cancer
Hyun Woo Lee et al.
LUNG CANCER (2008)
Increased β1 integrin is associated with decreased survival in invasive breast cancer
Evelyn S. Yao et al.
CANCER RESEARCH (2007)
Fast, hungry and unstable: finding the Achilles' heel of small-cell lung cancer
Christine L. Hann et al.
TRENDS IN MOLECULAR MEDICINE (2007)
Prognostic value of immunohistochemical staining of p53, bcl-2, and Ki-67 in small cell lung cancer
KH Paik et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2006)
Applications of tissue microarray technology in immunohistochemistry: A study on C-kit expression in small cell lung cancer
V Donati et al.
HUMAN PATHOLOGY (2004)
Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis
B Martin et al.
BRITISH JOURNAL OF CANCER (2003)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
Fibroblast growth factor-2 induces translational regulation of Bcl-XL and Bcl-2 via a MEK-dependent pathway -: Correlation with resistance to etoposide-induced apoptosis
OE Pardo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines
UA Sartorius et al.
INTERNATIONAL JOURNAL OF CANCER (2002)